Kowsar Alam

Kowsar Alam

Auto-generated profile, based on publicly available information

Kowsar Alam

Department of Physics University of Chittagong Chattogram 4331 Bangladesh

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
ATAbhimanyu Thakur
Abhimanyu Thakur
RSRakesh Kumar Sidu
Rakesh Kumar Sidu
HZHeng Zou
Heng Zou
KAKowsar Alam
Kowsar Alam
MYMengsu Yang
Mengsu Yang
YLYoungjin Lee
Youngjin Lee
Background: Malignant glioma is a fatal brain cancer. Accumulated evidence has demonstrated that exosomes can cross the blood–brain barrier (BBB), suggesting their potential use as drug delivery vehicles to glioma. Therefore, various loading methods of anticancer agents into exosomes have been developed. However, the loading efficiency of anticancer drugs, such as doxorubicin (DOX) and paclitaxel (PTX), into exosomes is relatively low, thus challenging to improve the drug delivery efficiency to glioma cells (GMs) via exosomes. Methods: To improve the loading efficiency of doxorubicin into exosomes, a microfluidic device (Exo-Load) was developed. Next, to increase the exosomal delivery of doxorubicin to GMs, autologous exosomes were used for its loading via Exo-Load. Briefly, exosomes from SF7761 stem cells-like- and U251-GMs were isolated and characterized by nano-tracking analysis (NTA), transmission electron microscopy (TEM), and immunogold EM. Finally, doxorubicin was successfully loaded into exosomes with saponin by Exo-Load, and the uptake and functionality of doxorubicin-loaded exosomes for parent GMs were evaluated. Results: The loading efficiency of DOX into SF7761 stem cells-like- and U251-GMs-derived-exosomes were 19.7% and 7.86% via Exo-Load at the injection flow rate of 50 μL/min, respectively. Interestingly, the loading efficiency of DOX into U251 GMs-derived exosomes was significantly improved to 31.98% by a sigmoid type of Exo-Load at the injection flow rate of 12.5 μL/min. Importantly, DOX-loaded GMs-derived exosomes via Exo-Load inhibited parent GMs’ proliferation more than heterologous GMs, supporting exosomes’ homing effect. Conclusion: This study revealed that DOX and PTX could be loaded in exosomes via Exo-Load, demonstrating that Exo-Load could be a potential drug-loading device into exosomes with further optimization. This study also demonstrated that the delivery of DOX to SF7761 GMs via their daughter exosomes was much more efficient rather than U251 GMs-derived exosomes, supporting that the use of autologous exosomes could be better for glioma drug targeting.

1 December 2018 in Analytica Chimica Acta
Verified
Journal Article
Closed access
KAKowsar Alam
Kowsar Alam
EKEmmanuel Koomson
Emmanuel Koomson
HZHeng Zou
Heng Zou
CYChangqing Yi
Changqing Yi
CLCheuk-Wing Li
Cheuk-Wing Li
MYMengsu Yang
Mengsu Yang

31 August 2023 in Advanced NanoBiomed Research
Verified
Journal Article
Open access
KAKowsar Alam
Kowsar Alam
Nanocarrier‐mediated drug delivery in life science and patient care is now highly recognized and has gained significant traction in pharmaceuticals for clinical applications. Besides, the incorporation of microfluidic technology for the synthesizing and delivery of nanocarriers facilitates preclinical drug testing under biomimicking physiological conditions, which further increases the prospect of nanocarrier drug delivery systems in clinical use. Indeed, an inherent amenability of microfluidics shows fine‐tuned manipulation and controlled release of nanocarrier drugs in a spatiotemporal manner. The progress of microfluidic‐assisted potential drug delivery platforms is reviewed and summarized with a focus on factors determining the design of novel nanodrug delivery microfluidic systems, on‐chip functionalization and synthesis mechanisms of nanodrugs, and stimulation‐responsive and organ‐specific drug delivery platforms, including different challenges associated with developing platforms in benchtop research that hinder platforms’ clinical translation. Moreover, the commercial scenario and prospects of the microfluidic nanodrug delivery platforms are evaluated, and further predictive suggestions are provided for developing multitargeting microfluidic/organ‐on‐a‐chip nanodrug delivery platforms and overcoming the challenges associated with commercialization. This review recognizes that although numerous reports have reinforced the promise of microfluidic nanodrug delivery platforms, much remains to be done in lab and benchtop works to realize it in clinical practice through commercialization.

1 June 2021 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
AIA. M. Olabisi Ilyas
A. M. Olabisi Ilyas
KAKowsar Alam
Kowsar Alam
JMJamal - Deen Musah
Jamal - Deen Musah
LSLin Oo Saw
Lin Oo Saw
SVShishir Venkatesh
Shishir Venkatesh
CLCondon LAU
Condon LAU
The working electrode’s surface property is crucial to cell adhesion and signal collection in electric cell-substrate impedance sensing (ECIS). To date, the indium tin oxide (ITO)-based working electrode is of interest in ECIS study due to its high transparency and biocompatibility. Of great concern is the impedance signal loss, distortion, and data interpretation conflict profoundly created by the movement of multiple cells during ECIS study. Here, a carboxyl-terminated ITO substrate was prepared by stepwise surface amino silanization, with N-hydroxy succinimide (NHS) and 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride (EDC) treatment, respectively. We investigated the stepwise changes in the property of the treated ITO, cell-substrate adhesion, collective cell mobility, and time course of change in absolute impedance from multiple Chinese hamster ovary (CHO) cells [(Δt-Δ|Z|)CELLS]. The carboxyl-terminated ITO substrate with a surface roughness of 6.37 nm shows enhanced conductivity, 75% visible light transparency, improved cell adherence, reduced collective cell migration speed by approximately twofold, and diminished signal distortion in the [(Δt-Δ|Z|)CELLS]. Thus, our study provides an ITO surface-treatment strategy to reduce multiple cell movement effects and to obtain essential cell information from the ECIS study of multiple cells through undistorted (Δt-Δ|Z|)CELLS.